<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADeeply_subordinated_notes</id>
	<title>Definition:Deeply subordinated notes - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADeeply_subordinated_notes"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Deeply_subordinated_notes&amp;action=history"/>
	<updated>2026-04-29T09:35:27Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Deeply_subordinated_notes&amp;diff=12218&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Deeply_subordinated_notes&amp;diff=12218&amp;oldid=prev"/>
		<updated>2026-03-12T09:56:16Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🔗 &amp;#039;&amp;#039;&amp;#039;Deeply subordinated notes&amp;#039;&amp;#039;&amp;#039; are a form of hybrid capital instrument issued by insurance and reinsurance groups that sits near the bottom of the creditor hierarchy — senior only to equity — and typically features very long or perpetual maturities, optional deferral of coupon payments, and, in some structures, principal write-down or conversion mechanisms. Within the insurance sector, these instruments serve a specific regulatory purpose: they allow carriers to bolster their [[Definition:Own funds | own funds]] and improve [[Definition:Solvency ratio | solvency ratios]] without diluting shareholders, while qualifying as restricted-tier capital under the applicable prudential framework.&lt;br /&gt;
&lt;br /&gt;
⚙️ Under [[Definition:Solvency II | Solvency II]], deeply subordinated notes typically classify as Tier 1 or Restricted Tier 1 capital, subject to limits on the proportion of the [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]] they can cover. The instruments must incorporate loss-absorption features — such as the ability for the issuer to defer coupons on a non-cumulative basis or to write down principal — to count toward the highest quality capital tiers. In the United States, equivalent instruments may receive equity credit from [[Definition:Rating agency | rating agencies]] and factor into [[Definition:Risk-based capital (RBC) | risk-based capital]] calculations, though the precise regulatory treatment differs from European rules. Major groups like [[Definition:AXA | AXA]], [[Definition:Allianz | Allianz]], and [[Definition:Zurich Insurance Group | Zurich]] have been active issuers, calibrating their use of deeply subordinated notes alongside [[Definition:Subordinated debt | subordinated debt]] and retained earnings to optimize their capital stack. In Asian markets, similar instruments are emerging as regulators in jurisdictions like China (under [[Definition:C-ROSS | C-ROSS]]) and Japan refine their own tiered capital frameworks.&lt;br /&gt;
&lt;br /&gt;
💡 For investors, deeply subordinated notes occupy an unusual niche: they offer yields materially above senior or even subordinated insurance debt, reflecting the additional risk of coupon deferral and deep subordination in a liquidation scenario. For the issuing insurer, the trade-off is attractive — the instruments count as high-quality regulatory capital, their coupon payments are typically tax-deductible (unlike common [[Definition:Dividend | dividends]]), and they avoid the immediate dilution associated with an equity raise. However, the complexity of their terms means that pricing, investor communication, and regulatory approval require careful management. Issuance windows tend to cluster in periods of favorable credit market conditions, and the outstanding stock of deeply subordinated notes across the global insurance industry has grown substantially since [[Definition:Solvency II | Solvency II]] implementation encouraged European insurers to diversify their capital sources beyond retained earnings and common equity.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Own funds]]&lt;br /&gt;
* [[Definition:Subordinated debt]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Debt gearing]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Hybrid capital]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>